Drug intelligence / Profile preview

propofol + lidocaine

Development stage
Phase 4
Lead developer
AkzoNobel
Modality
Small Molecules
Administration
Intravenous
01

Overview

Propofol + lidocaine is a combination of two pharmaceutical agents commonly used in anesthesia practice. Propofol is an intravenous anesthetic agent that acts primarily as a positive allosteric modulator of the gamma-aminobutyric acid type A (GABA-A) receptor, enhancing inhibitory neurotransmission and inducing sedation and hypnosis[8]. Lidocaine is an amide-type local anesthetic that stabilizes neuronal membranes by inhibiting sodium ion channels, thereby blocking nerve impulse conduction and providing local anesthesia[6]. The combination is primarily used to reduce the pain associated with propofol injection during induction of anesthesia. Lidocaine can be administered either mixed with propofol or as a separate injection prior to propofol administration, significantly reducing the incidence and severity of injection pain through both local anesthetic effects at the vascular endothelium and central analgesic mechanisms[1][2][3][5]. This synergistic use does not alter the required dose for induction but may destabilize the emulsion if mixed directly[3][4].

Other names
lidocaine and propofolpropofol with lidocainelidocaine admixture with propofol
02

Targets

Glycine receptorGABRB2 (GABA-A receptor subunit beta-2)GABRB3 (GABA-A receptor subunit beta-3)SCN2A (Voltage-gated sodium channel protein type 2 subunit alpha)SCN4A (Voltage-gated sodium channel protein type 4 subunit alpha)

Beyond the preview

Go deeper on propofol + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on propofol + lidocaine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call